Pinealon
A synthetic tripeptide studied in limited research for neuroprotection, brain aging, and cellular stress responses.
OVERVIEW
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed and studied for possible neuroprotective and aging-related effects. Published human evidence and pharmacokinetic data are sparse.
Proposed Mechanisms
• Proposed gene-expression effects related to neuronal repair • Cellular stress-response signaling
Potential Applications
• Cognitive-decline research • Healthy-brain-aging research • Stroke-recovery research • Neuroprotection research
Pharmacokinetics
Intranasal and injectable routes have been investigated. Rapid mucosal absorption and CNS penetration have been proposed, but human half-life, metabolism, and elimination are not well characterized.
Dosing
No standardized or FDA-recognized dosing regimen. Published research protocols vary, so no evidence-based clinical dose can be recommended.
Monitoring
No validated clinical monitoring protocol exists outside research settings.
Side Effects
Short-term tolerability has been described in limited reports, but robust randomized human safety data are lacking.
Contraindications
No FDA-approved labeling or established contraindication profile.
FDA/Investigational Status
Investigational. No FDA-approved U.S. drug or indication was identified in the sources reviewed as of the verification date; confirm current status in Drugs@FDA before publication.
Disclaimer/Notes
Educational resource only. Regulatory status is an inference from the current approval database and should be rechecked periodically.
Clinical Review Status
Clinical + legal review required before publishing